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Abstract
Background: Hepatitis B vaccination was introduced into the Expanded Program of Immunization in Colombia in
1992, in response to WHO recommendations on hepatitis B immunization. Colombia is a low endemic country for
Hepatitis B virus infection (HBV) but it has several high endemic areas like the Amazon basin where more
than 70 % of adults had been infected. A cross- sectional study was carried out in three rural areas of the
Colombian Amazon to evaluate compliance with the recommended schedule for hepatitis B vaccine in
Colombian children (one monovalent dose given in the first 24 h after birth + 3 doses of a pentavalent
containing Hepatitis B. (DPT + Hib + Hep B).
Methods: A household survey was conducted in order to collect vaccination data from children aged from 6 months
to <8 years. Vaccination status was related to sociodemographic data obtained from children caretakers.
Results: Among 938 children above 6 months and < 8 years old studied, 79 % received a monovalent dose of hepatitis
B vaccine, but only 30.7 % were vaccinated in the first 24 h after birth. This proportion did not increase by age or
subsequent birth cohorts. Coverage with three doses of a DTP-Hib-HepB vaccine was 98 %, but most children did not
receive them according to the recommended schedule. Being born in a health facility was the strongest predictor of
receiving a timely birth dose.
Conclusions: This study suggests that more focused strategies on improving compliance with hepatitis B birth dose
should be implemented in rural areas of the Amazon, if elimination of perinatal transmission of HBV is to be achieved.
Increasing the proportion of newborns delivered at health facilities should be one of the priorities to reach that goal.
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Background
Perinatal transmission of hepatitis B virus ends in chronic
hepatitis B infection in 80 to 90 % of the children exposed
to the virus, while less than 1 % of newborns develop the
acute form of the disease [1, 2]. Mathematical models
estimate that 21 % of all hepatitis B virus (HBV) related
deaths are attributable to infection in the perinatal period,
and 48 % to infection in early childhood. Vaccinating
50–90 % of newborns would prevent 77 to 84 % of
Hepatitis related deaths because it reduces by 70 to 95 %
the risk of HBV transmission from mother to child [3]. In
1992, WHO recommended universal vaccination against
HBV due to the high burden of the HBV-related diseases
worldwide and later, in 2004, it endorsed the use of a birth
dose to prevent perinatal transmission [1]. Although uni-
versal hepatitis B vaccination was introduced in Latin
America countries (LAC) since mid-1990, there is a pau-
city of information on the quality of the vaccination
process and its impact on HBV transmission across the
region [4]. Colombia has several high endemic spots
placed in deep rural areas including the Amazon basin.
In the pre-vaccination era, carriage of HBV surface anti-
gen (HBsAg) was above 8 % and outbreaks of fulminant
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Hepatitis were common in those places [5]. In Colombia,
universal vaccination against HBV for children was intro-
duced in 1992 in a 0-1-2 schedule with a monovalent
hepatitis B vaccine. In 1999, a field evaluation of the
vaccination program found a reduction in HBV infection,
but vaccination coverage with birth dose was low (25 %)
and subsequent doses lagged compared to DPT vaccine
[6]. To improve prevention, in 2001 Colombia modified
the HBV vaccine schedule, switching from 3 monovalent
doses to 3 doses of a pentavalent vaccine (diphtheria,
tetanus, pertussis, Haemophilus influenzae type b and
hepatitis B) plus one monovalent birth dose.
In 2011, a serological survey was carried out in a sample
of children living in rural areas of the Colombian Amazon
aiming to assess the prevalence of HBV infection and
HBsAg carriage after the change of HBV vaccine schedule.
This paper describes the findings related to compliance




A population-based household survey was conducted to
assess vaccination coverage and its characteristics in the
Colombian Amazon department among children above
6 months and < 8 years old. Age was restricted because
only children < 8 years. old were exposed to the vaccination
schedule under study.
Study population
The municipalities included in the survey were Leticia,
Puerto Nariño, and Tarapacá. Leticia is the capital of the
department of the Amazon with an estimated population
of 39,667 inhabitants with 37 % living in rural areas.
Puerto Nariño is the second most populated municipal-
ity with 7574 inhabitants, 73.3 % living in the rural area.
Tarapacá is a rural area with small human settlements
scattered along the banks of the Putumayo and the
Cothue rivers with a population of 3992 inhabitants.
Leticia and Puerto Nariño were chosen because they
have the largest population in the department. Tarapacá
was selected as representative of the most isolated rural
areas where a substantial proportion of the Amazon
population lived.
Sample size
The main goal of this study was to assess the prevalence
of HBV infection and HBsAg carriage among children
living in rural areas of the Amazon. Sample size was
calculated to assess an HBsAg carriage prevalence of 1 %
within a confidence limit of 0.5 and 95 % of confidence
level. The number needed to fulfill those assumptions
was estimated to be ~1300 children. At the end, more
than 900 children < 8 years were available for the analysis
on vaccine coverage. That sample size would be enough
to estimate a vaccination coverage of 80 % with confidence
limits of 8 %.
Sampling criteria
For Leticia and Puerto Nariño, only rural areas settled
along the Amazon river (pop < 8 years ≈ 2700 according
to EPI field census) were included in the study because
HBsAg carriage was considerably higher and vaccination
was lower than in urban settlements or rural areas
placed elsewhere. [6–8]. Most people belong to aborigi-
nal tribes and live under the poverty line with low access
to health and sanitation services. In Leticia 12 of 21
villages were included; in Puerto Nariño 17 villages out
of 20 were included and in Tarapacá, 8 communities out
of 13 were included. Six communities were excluded
because of a very low population (only one family) or
language constraints. One community (YAGUAS) rejected
to participate in the study.
Community and tribal leaders in every municipality
were invited to a meeting, conducted by the researchers,
where they were briefed about the following issues:
objectives of the study, importance of hepatitis B infec-
tion for their communities, relevance of the vaccination
program for hepatitis B control, and the relevance of
monitoring infection prevalence periodically.
Once a community approved to participate in the
study, field workers started household visits in order to
find out the information on vaccination status of every
child who match the inclusion criteria within the house-
hold. All children born from 2004 onwards, present at
the time of the visit and whose parents consented to
participate in the study were included. A household was
defined as all those sleeping under the same roof regu-
larly. The field work team was composed of bacteriolo-
gists, nurses, and a field coordinator. The survey was
conducted between July 2011 and March 2012.
For Leticia and Puerto Nariño participants were selected
from villages settled along the banks of the Amazon River
and the Loretoyaco River. It was restricted to those settle-
ments because they tend to have lower coverages and
higher HBV prevalence than areas accessible by road [6].
Selection of participants
In the villages selected for the study every household
was visited and parents invited to participate in the
study. All eligible children found in any given household
were included in the study if their caretakers approved
to participate. Households were visited starting from the
farthest to the nearest to the center of the community.
Hepatitis B vaccination data
Vaccination dates were recorded from vaccination cards.
When vaccination cards were not available or difficult to
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read the Expanded Program on Immunization (EPI)
databases were consulted. These databases are updated
by the EPI nurses and contain vaccination data from
every child living in rural areas. Recall data was not
used. A timely birth dose should be given in the first
24 h after delivery as recommended by the WHO [1];
however in our study, vaccination cards show dates of
birth and administration of monovalent HBV dose but
lack data on both, exact hour of birth or hour of vaccine
administration. Therefore, a timely birth dose was defined
as a monovalent dose of the hepatitis B vaccine adminis-
tered on the same date of delivery or the day after. A timely
vaccinated child was described as having a timely monova-
lent dose plus 3 doses of pentavalent vaccine given at 2, 4
and 6 months with at least 30 days between each dose.
The research protocol was approved by the medical
ethics committee of the school of medicine, Universidad
Nacional de Colombia, October 8, 2010. All participants
were informed of the purpose and procedures of the
study and all the parents or legal guardians gave their
signed consent for their children to participate.
Independent variables
The following variables were collected : 1) vaccination
status, 2) mother’s education level, 3) level of wealth
measured by ownership of boat or electric appliances, 4)
overcrowding (defined as more than 5 people per room),
5) mother’s ethnic group, 5) children sex, 7) site of birth
(home, health care facility other), 8) person attending
birth, 9) child’s health insurance regime for which there
were three options: belonging to the Contributive regime
or to the Subsidized regime. In Contributive regime
workers in the formal sector pay a monthly sum and
have access to a wider health care set of services. The
Subsidized regime is designed for informal workers who
pay a lower sum and are entitled to a more restrictive
health care portfolio. It should be emphasized that hepa-
titis B vaccine is provided freely by the Colombian M o
H and every child has the right to be vaccinated regard-
less his/her insurance scheme.
Statistical analysis
Information was entered into databases using EpiInfo
3.5.3 ®, and statistical analysis were performed in SPSS 19®
and Stata 11.1 ® software. Coverage with the birth dose,
coverage with a timely birth dose and mean time to the
monovalent hepatitis B vaccine dose were described by
birth cohort. An inverse Kaplan-Meier curve was used to
describe coverage and timeliness of vaccination with the
monovalent birth dose. To identify predictors of receiving
a timely birth dose of monovalent hepatitis B vaccine,
bivariate analysis were conducted relating it to the follow-
ing independent variables: municipality, mother’s educa-
tion level, household wealth, crowding, ethnic group, child
sex, site of birth, and child’s health insurance. Odds Ratios
(OR), 95 % confidence intervals, and p values were esti-
mated to assess the strength and statistical significance of
those associations. All independent variables found related
to timely monovalent dose (p < 0.1) were included in a
multivariate model (unconditional logistic regression)
using a stepwise approach.
Children were selected using villages as the sampling
unit, so children in a specific village tended to be similar,
but different, in a range of characteristics, compared to
children in a different village. This “clustering effect”
may lead to underestimate the magnitude of the variance
of the OR estimates. Hence, a mixed-effects logistic re-
gression analysis was performed to control for that clus-
ter effect. The model was built using the same strategies
described for the unconditional logistic regression. Results
from both models were compared and, if no important
difference was observed, only results from the simple
model was presented. Timely vaccination with pentavalent
was assessed in a similar way.
To assess the direction and magnitude of potential
selection biases introduced by children without vaccin-
ation card, additional analysis were conducted. Children
without a valid vaccination card, whose vaccination
record could not be recovered from EPI local registries,
were classified as no vaccinated and were included in
the analysis. Then, changes in ORs values were noted
and appraised if they occur. To assess the influence of
potential information bias, an additional analysis was
conducted classifying as unvaccinated the 30 children
without vaccination card.
Results
A total of 938 children aged 6 months to 8 years were
included and vaccination card was available for 97 % of
them. Children in the study represented between 24 and
48 % of the total number of eligible children living in
the rural areas of the surveyed municipalities. The larger
proportion of rural children, compared to the total rural
population in each municipality, was selected from
Puerto Nariño and Tarapacá, 48 and 45 % respectively.
In Leticia, 24 % out of all children living in rural areas
were surveyed, Less than 1 % of parents invited to
participate refused. One community, representing less
than 10 % of the total population living in the rural
settlements along the Amazon River, declined to partici-
pate in the study.
The mean age of the participants was 3.7 years (CI 95 %
3.5–3.8), and the median was 4 years, IQR (interquartile
range) of 4. Males represented 51.6 % of the sample. Most
children, 79.4 % (747) (CI 95 % 77–82.3 %), received a
hepatitis B monovalent dose, only 30.7 % (n = 288) filled
the definition for a timely birth dose. On average, children
received the monovalent dose 14 days after delivery (95 %
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CI 12.8–15.3) with a median of 8 days, IQR = 23. Figure 1
shows the inverse survival curve of the progression of the
vaccination. The median time from delivery to birth dose
is presented in Figs. 2 and 3 depicts the proportion of
children with a timely birth dose by birth cohort. The
highest coverage with a timely birth dose was observed for
children born in 2006 (46 %), Fig. 2 shows that the median
time to receive the birth dose in 2006 was 3 days.
Table 1 displays the results of the bivariate and multi-
variate analysis relating the characteristics of vaccinated
children with timeliness of hepatitis B monovalent dose.
Bivariate analysis showed that place of birth (hospital), mu-
nicipality, race, wealth, and overcrowding were associated
with receiving a timely birth dose of hepatitis B vaccine.
In the final multivariable model, only place of birth and
municipality remained associated with receiving a timely
birth dose of hepatitis B. (Table 1). The variable “birth
assisted by” was dropped from the model because it was
highly correlated with the place of birth. Children born at
health facilities had a disproportionate chance of receiving
a timely birth dose compared to those born elsewhere.
(OR 27.2, 95 % CI 18.5–40). Living in the main village of
Tarapacá (where the hospital is located) or in the rural
areas of Leticia increased the chance of getting a timely
birth dose of hepatitis B monovalent vaccine.
The model where the children without a vaccination
card were classified as unvaccinated yielded similar re-
sults. The place of birth was still the strongest associated
variable (OR22.6 CI 95 % 15–34.1) with not being vac-
cinated. A mixed effects model was run using the same
variables than the conventional logistic regression. No
differences were found for the results of both models and
goodness of fit was better for the conventional logistic
regression model (Likelihood Ratio test = 8.3, p = 0.002).
Vaccination with the pentavalent vaccine
Coverage was 99.7 % (95 % CI 99.1–99.9 %) for the first
dose, 99.3 % (95 % CI 98.5–99.7 %) for the second and
98.2 % (95 % CI 97.1–98.9 %) for the third. Most
children, 78.3 %, received a monovalent dose plus three
pentavalent doses. The first pentavalent dose was re-
ceived, on average, at 92.7 days (95 % CI 87.9–97.6),
median of 74 and IQR (interquartile range) of 37; the
second dose at 169 days (95 % CI 163–176), median of
144 and IQR of 57; the third dose was given at 251 days
(95 % CI 242–260), median of 209 and IQR of 71. Only
15.7 % of the children were vaccinated as recommended
by the WHO and the Colombian EPI guidelines. Timely
vaccination with pentavalent increased among those
living in a household with less than 5 people/room (OR
Fig. 1 Proportion of children vaccinated with the hepatitis B birth dose. Leticia, Nariño, Tarapacá; Amazon department, Colombia.1- SKM (t)
representing the proportion of children being vaccinated with a monovalent hepatitis B dose at any given age (t). The last children vaccinated
received a monovalent hepatitis B dose 164 days after being born
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1.7 CI 95 % 1.2–2.5); born in a health facility (OR 1.5 CI
95 % 1.1–2.1); or having a more educated mother. (OR
1.085 CI 95 % 1.028–1.1/year of education).
Discussion
This study shows that coverage with a timely birth dose of
HBV vaccine is still low among high risk populations,
which makes elimination of perinatal transmission very
challenging for these areas. In 1999, a probabilistic sample
of rural and urban children living in the Colombian Ama-
zon, found that a timely birth dose only reached to 25 %
of children born after the beginning of HBV vaccination.
Though the methodology of the 1999 survey is different
and caution should be exerted when comparing results,
the 2011 study also found a low coverage with hepatitis B
birth dose, suggesting a lasting low effectiveness of the
primary health care system in the Amazon. [6]. Only two
studies describing coverage with HBV birth dose have
been published from Latin American countries.
Among children born in health facilities (n = 320),
94 % received the monovalent dose and 72.5 % got it
timely. From the remaining children, 69 were vaccinated
with the monovalent within 87 days after birth, and 19
did not receive it.. Nationwide, the Colombian EPI re-
ports that at least 80 % of newborns received a monova-
lent hepatitis B dose, but there is no data on how many
receive it within the first 24 h after birth. Our survey
showed that although monovalent dose is reported on
vaccination card as a birth dose, yet 50 % of children re-
ceived it more than 8 days after birth. It suggests that
the actual coverage with a birth dose of hepatitis B in
Colombia may be lower than the official report.
The introduction of a pentavalent vaccine seems to
have increased the proportion of children receiving three
doses of hepatitis B. Before the introduction of pentava-
lent, the Colombian EPI reported that less than 80 % of
children have received three doses of hepatitis B by the
age of one year. Nowadays, more than 90 % of children
across the nation received three doses of hepatitis B in
the first year of age, and this increase is partially an
impact of switching from monovalent to pentavalent.
However, our study shows that most children received
three doses of pentavalent but that they are delayed.
Our study have some methodological strengths. Infor-
mation bias was avoided by using only written informa-
tion on vaccination status either from vaccination cards
or local EPI records. To avoid mistakes while filling
study forms with vaccination data from EPI cards, field
workers were intensively trained to check for inconsist-
encies between among vaccination dates and birth dates.
Also, the database was programmed to check for similar
inconsistencies. Less than 5 % of the records were found
with such inconsistencies and most of them were cor-
rected. Actions were taken to reduce potential selection
bias. Meetings with leaders of the communities previous
to the beginning of field work helped to improve partici-
pation rates. During the field work, households were
visited in a pre-established order to avoid volunteering.
As a result of those strategies, less than 1 % of the
parents invited refused to take part in the study. Only
one community, the Yaguas, rejected to participate in
the study but they represent less than 10 % of the total
population living in the rural settlements along the
Amazon River, Therefore its impact on vaccine coverage
estimation should be negligible.
There were also potential threats for validity. One of the
most important was the likelihood of selection bias because
villages were selected using a non-probabilistic sampling
method. As described in methods, we were interested in
studying those areas known to have a high prevalence of
Hepatitis B infection where good vaccination practices are
more critical. In spite of using a non-probabilistic sample,
results are consistent with national estimates, as for the
proportion of children receiving three doses of pentavalent.
They are also consistent with international findings, as for
the relation between being born in a health facility and the


















































Fig. 3 Proportion of children receiving a timely hepatitis B birth
dose by birth cohort. Leticia, Puerto Nariño, Tarapacá; Amazon

































Fig. 2 Median days to hepatitis B birth dose according to the
birth cohort. Leticia, Puerto Nariño, Tarapacá; Amazon
department, Colombia
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Table 1 Selected variables associated with timely vaccination with the hepatitis B birth dose. Leticia, Puerto Nariño, Tarapacá;
Amazon department, Colombia 2011–2012
Birth dosea
n Missing Vaccinated Not vaccinated Crude OR Adjusted ORb
p value p value
Sex p = 0.207
Female 453 2 28.7 %(130) 71.3 %(323)
Male 483 32.5 %(157) 67.5 %(326)
936
Municipality p < 0.0001 p < 0.0001 p < 0.001
Leticia 334 0 38.6 %(129) 61.4 %(205) – –
Puerto Nariño 397 25.9 %(103) 74.1 %(294) 0.6 (0.4–0.8) 0.6 (0.4–0.8)
Tarapacá rural 156 16 % (25) 74.1 % (131) 0.3 (0.2–0.5) 0.3 (0.2–0.6)
Tarapacá main village 51 60.8 %(31) 39.2 %(20) 2.5 (1.3–4.5) 1.0 (0.5–2.2)
938
Place of birth p < 0.0001 p < 0.0001 p < 0.001
Health care facility 320 9 72.5 %(232) 27.5 %(88) 28.2 (19.4–41.1) 27.2 (18.5–40)
Other 609 8.5 %(52) 91.5 %(557) –
929
Ethnic group of the mother p = 0.008 p = 0.009
Ticuna 714 0 28.4 %(203) 71.6 %(511) 0.4 (0.2–0.8)
Other 180 35.6 %(64) 64.4 %(116) 0.6 (0.3–1.2)
None 44 47.7 %(21) 52.3 %(23) –
938
Appliances in the household (Boat, refrigerator, television or radio) p < 0.0001 p < 0.0001
One or more 558 5 36.7 %(205) 63.3 (353) 2.1 (1.6–2.8)
None 375 21.6 %(81) 78.4 %(294) –
933
Birth assisted by p < 0.0001 p < 0.0001
doctor or nurse 318 9 72.6 %(231) 27.4 %(87) 28 (19.2–40.6)
Other 611 8.7 %(53) 91.3 %(558) –
929
Overcrowding p = 0.001 p = 0.001
0–5 people/room 645 12 33.6 %(217) 66.4 %(428) 1.7 (1.2–2.3)
>5 people/room 281 23.1 %(65) 76.9 %(216) –
Health insurance p = 0.01 p = 0.013
None 46 17 80.4 %(37) 19.6 %(9) 0.2 (0.07–0.6)
Subsidized 849 30.5 %(259) 69.5 %(590) 0.4 (0.2–0.8)
Contributive (paid by the affiliated) 26 53.8 %(14) 46.2 %(12) –
921
Mother’s education (mean years) p < 0.0001 p < 0.0001
938 0 4.23 3.33 1.1 (1.0–1.1)
aTimely birth dose defined as a monovalent dose of the hepatitis B vaccine administered on the same date of delivery or the day after
blogistic regression
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Low birth dose coverage has been reported in other
endemic countries such as China, India, and Cambodia,
where it ranged from 3 to 36 % in rural areas [9, 10].
Only one study was found from other Latin American
country, Brazil, where birth dose coverage was 40.4 % in
27 urban areas with an even lower coverage endemic
regions [11]. Studies from China and Cambodia found
similar factors associated with timely birth dose, being
born at a health facility, parent’s awareness about hepa-
titis B vaccine birth dose, and mother’s education [9, 10].
Most children in Colombia (95.4 %) are delivered at
health facilities and only 4.3 % are delivered at home.
However, this proportion is higher for rural areas
(12.1 %) and the Amazon has the highest proportion of
non-institutional birth in the country (31 %) [12]. We
found a higher proportion of home deliveries, 66 %,
which could be attributed to our sample being drawn
from rural areas.
In the present study, up to a third of children delivered at
hospital did not receive a timely birth dose of hepatitis B.
Other studies (Papua New Guinea, The Philippines, and
Laos) found that factors associated to not receiving a timely
birth dose within health facilities included: poor knowledge
on vaccination policy, wrong contraindications, and lack of
knowledge on levels of hepatitis B infection in the target
population [13–15]. Out of pocket expenses seem to be an
important barrier in developed countries [16].
Municipality predicted timely vaccination with hepatitis
B birth dose. Children living in the main village of Tara-
paca, where the local hospital is placed, and children from
the rural areas of Leticia, the capital of the department,
had a higher chance of being timely vaccinated. Dif-
ferences by geographical area occur because vaccinating
rural villages along the Amazonian rivers is quite expensive.
Vaccines and supplies are shipped from Leticia by boat or
plane, which is costly and unreliable, creating shortage of
both elements. Geographical barriers have been identified
in other developing countries too [17, 18].
There have been attempts to increase birth dose cover-
age using strategies that promote birth delivery at health
facilities or improving the opportunity to receive a birth
dose among those born at home. Using out- of -the
-cold chain stored vaccines increased birth dose cover-
age for children delivered at home, without decreasing
antibody response or increasing vaccine wastage. Initia-
tives to increase the proportion of births at hospital
facilities have also succeeded to increase the proportion
of children receiving birth dose properly [16, 19–22].
Conclusions
In spite the low coverage with the birth dose and difficul-
ties to comply with the recommended schedule, studies
from the Amazon in Colombia showed that there have
been dramatic reductions in the prevalence of infection
and carriage after universal hepatitis B vaccination was
introduced [8, 23, 24]. However, if elimination of perinatal
transmission is to be reached in the Amazon it would be
mandatory to increase the proportion of newborns receiv-
ing a timely birth dose. Current strategies should include
the frequent training and retraining of health workers on
catch-up schedules and on ways to increase the propor-
tion of women giving birth at health care facilities.
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